A Study to Evaluate the Safety and Pharmacokinetics with MEDI8367 Administered in Healthy Subjects, and in Subjects with Chronic Kidney Disease

Trial Identifier: D6361C00001
Sponsor: AstraZeneca
Collaborator:
Parexel International (IRL) Limited
NCTID:: NCT04365218
Start Date: July 2020
Primary Completion Date: January 2021
Study Completion Date: January 2021
Condition: Chronic Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
US, CA Glendale, CA, US, 91206